10X Genomics (TXG) Stock Price
$10.9 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
4 -
Technical
1
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on 10X Genomics, AI stock picks, stock alerts and much more.
TXG AI Stock Analysis
Financial Performance
The financial performance of 10X Genomics appears to be struggling. With a reported revenue of $151.7M in the last quarter, it has seen a decline by -0.9% from the previous quarter and down by -17.6% year over year. The gross profit was also down by -0.5%. Operating income was -$41.5M, although this saw a minor increase of 0.6% from the previous quarter, it's still down by -16.5% YoY indicating some concerns about profitability.
Stock Price
The stock price is currently at $14.81 with an uptick of 4.3% in the past month but has declined significantly by -65.7% YoY which indicates bearish trends for investors in the long term despite recent gains.The RSI value at 46 suggests neither overbought nor oversold conditions while the stock's current price is below its 200-day moving average ($20), indicating a downtrend.
Alternative Data Signals
Website traffic shows modest growth with visitors per month up by 1.9%, which might suggest increased interest or engagement with their products or services.However, job postings are down by -25% YoY suggesting potential cost-cutting measures or slower growth expectations.Employee sentiment remains positive with an estimated two-thirds reporting a positive business outlook.Social media followers have remained relatively stable with slight decrease on Twitter and increase on Facebook.
Conclusion
In conclusion, based on financial performance and stock price trends, there seems to be significant challenges facing 10X Genomics that may impact its stock performance negatively.Despite some positive signals such as website traffic and employee sentiment, the overall stock analysis for 10X Genomics is bearish.
Note: This AI Stock Analysis is based on data as of January 26. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
10X Genomics (TXG) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of 10X Genomics (TXG), currently trading at $10.9, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About TXG
-
10x Genomics, Inc.
-
Symbol
TXG
-
Market
NASDAQ
-
Industry
Medical - Healthcare Information Services
-
Market Cap
1.3B
Similar Stocks
 |
GoodRx GDRX |
$4.81 1% |
5 |
 |
GE HealthCare GEHC |
$91.09 1.1% |
6 |
 |
Schrodinger SDGR |
$22.64 5.7% |
6 |
 |
Spok SPOK |
$16.43 3.2% |
6 |
 |
Health Catalyst HCAT |
$5.23 3% |
3 |
News
TXG Alternative Data
Web Traffic
10X Genomics receives an estimated 281155 monthly visitors to 10xgenomics.com.
-
Web Traffic
281155
-
Change from Previous Month
16%
-
3 Month Change
14.3%
News Mentions
10X Genomics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
10X Genomics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
10X Genomics has 28,645 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.7% over the last month.
-
Twitter Followers
28645
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
1.1%
Facebook Engagement
10X Genomics has engaged 118 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
118
-
Daily Change
7.1%
-
1 Month Change
93.4%
-
3 Month Change
76.5%
Youtube Subscribers
10X Genomics has 6,440 subscribers on its main Youtube channel, up by 1.4% over the last month.
-
Youtube Subscribers
6440
-
Daily Change
0%
-
1 Month Change
1.4%
-
3 Month Change
3.9%
LinkedIn Followers
243,447 are following 10X Genomics on LinkedIn, up by 2.1% over the last month.
-
LinkedIn Followers
243447
-
Daily Change
0.1%
-
1 Month Change
2.1%
-
3 Month Change
5.5%
Job Postings
10X Genomics has an estimated 47 open job postings, which is down -23% over the last month.
-
Job Postings
47
-
Daily Change
4.1%
-
1 Month Change
23%
-
3 Month Change
31.9%
LinkedIn Employees
According to LinkedIn, 10X Genomics has 2,243 employees, up by 0.3% over the last month.
-
LinkedIn Employees
2243
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
2.2%
Business Outlook
-
Business Outlook
66
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
TXG Financials
TXG Key Metrics
-
Total Revenue
$151.7M
-
Net Income
-$35.8M
-
Earnings per Share
-$0.3
-
Free cash flow
$17.8M
-
EBITDA
-$23.7M
-
EBITDA Ratio
-0.156184
-
Total Assets
$937.8M
TXG 2-year Revenue & Income
TXG 2-year Free Cash Flow
TXG Technicals
TXG SMA
TXG RSI
FAQ
What's the current price of 10X Genomics (TXG) Stock?
The price of an 10X Genomics (TXG) share is $10.9.
What's the market cap of 10X Genomics?
The current market cap of 10X Genomics is 1.3B.
Should I buy or sell TXG?
10X Genomics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, 10X Genomics is better viewed as a hold or accumulate position while waiting for further developments.
Is 10X Genomics a good investment?
The current analysis of 10X Genomics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in 10X Genomics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy 10X Genomics (TXG) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for 10X Genomics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to 10X Genomics (TXG) that investors often compare it to?
10X Genomics (TXG) is often compared to similar stocks such as GoodRx, GE HealthCare, Schrodinger, Spok and Health Catalyst.
What is the forecast for 10X Genomics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast 10X Genomics' stock price to be around $10.37 in 2026. Starting from the current price of $10.9, this represents a 4.9% change in price, indicating a bearish outlook for the stock.
How to buy 10X Genomics (TXG) Stock?
10X Genomics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy 10X Genomics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.